Literature DB >> 32663192

SIV infection duration largely determines broadening of neutralizing antibody response in macaques.

Fan Wu1, Ilnour Ourmanov2, Andrea Kirmaier3, Sivan Leviyang4, Celia LaBranche5, Jinghe Huang6, Sonya Whitted2, Kenta Matsuda2, David Montefiori5, Vanessa M Hirsch2.   

Abstract

The development of broadly neutralizing antibodies (BNAbs) in HIV infection is a result of long-term coevolutionary interaction between viruses and antibodies. Understanding how this interaction promotes the increase of neutralization breadth during infection will improve the way in which AIDS vaccine strategies are designed. In this paper, we used SIV-infected rhesus macaques as a model to study the development of neutralization breadth by infecting rhesus macaques with longitudinal NAb escape variants and evaluating the kinetics of NAb response and viral evolution. We found that the infected macaques developed a stepwise NAb response against escape variants and increased neutralization breadth during the course of infection. Furthermore, the increase of neutralization breadth correlated with the duration of infection but was independent of properties of the inoculum, viral loads, or viral diversity during infection. These results imply that the duration of infection was the main factor driving the development of BNAbs. These data suggest the importance of novel immunization strategies to induce effective NAb response against HIV infection by mimicking long-term infection.

Entities:  

Keywords:  AIDS/HIV; Genetic variation; Immunoglobulins; Virology

Year:  2020        PMID: 32663192      PMCID: PMC7524488          DOI: 10.1172/JCI139123

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  51 in total

1.  Cooperation of B cell lineages in induction of HIV-1-broadly neutralizing antibodies.

Authors:  Feng Gao; Mattia Bonsignori; Hua-Xin Liao; Amit Kumar; Shi-Mao Xia; Xiaozhi Lu; Fangping Cai; Kwan-Ki Hwang; Hongshuo Song; Tongqing Zhou; Rebecca M Lynch; S Munir Alam; M Anthony Moody; Guido Ferrari; Mark Berrong; Garnett Kelsoe; George M Shaw; Beatrice H Hahn; David C Montefiori; Gift Kamanga; Myron S Cohen; Peter Hraber; Peter D Kwong; Bette T Korber; John R Mascola; Thomas B Kepler; Barton F Haynes
Journal:  Cell       Date:  2014-07-24       Impact factor: 41.582

2.  Viraemia suppressed in HIV-1-infected humans by broadly neutralizing antibody 3BNC117.

Authors:  Marina Caskey; Florian Klein; Julio C C Lorenzi; Michael S Seaman; Anthony P West; Noreen Buckley; Gisela Kremer; Lilian Nogueira; Malte Braunschweig; Johannes F Scheid; Joshua A Horwitz; Irina Shimeliovich; Sivan Ben-Avraham; Maggi Witmer-Pack; Martin Platten; Clara Lehmann; Leah A Burke; Thomas Hawthorne; Robert J Gorelick; Bruce D Walker; Tibor Keler; Roy M Gulick; Gerd Fätkenheuer; Sarah J Schlesinger; Michel C Nussenzweig
Journal:  Nature       Date:  2015-04-08       Impact factor: 49.962

Review 3.  Antibody-mediated neutralization and simian immunodeficiency virus models of HIV/AIDS.

Authors:  Shuji Sato; Welkin Johnson
Journal:  Curr HIV Res       Date:  2007-11       Impact factor: 1.581

4.  Effect of HIV Antibody VRC01 on Viral Rebound after Treatment Interruption.

Authors:  Katharine J Bar; Michael C Sneller; Linda J Harrison; J Shawn Justement; Edgar T Overton; Mary E Petrone; D Brenda Salantes; Catherine A Seamon; Benjamin Scheinfeld; Richard W Kwan; Gerald H Learn; Michael A Proschan; Edward F Kreider; Jana Blazkova; Mark Bardsley; Eric W Refsland; Michael Messer; Katherine E Clarridge; Nancy B Tustin; Patrick J Madden; KaSaundra Oden; Sijy J O'Dell; Bernadette Jarocki; Andrea R Shiakolas; Randall L Tressler; Nicole A Doria-Rose; Robert T Bailer; Julie E Ledgerwood; Edmund V Capparelli; Rebecca M Lynch; Barney S Graham; Susan Moir; Richard A Koup; John R Mascola; James A Hoxie; Anthony S Fauci; Pablo Tebas; Tae-Wook Chun
Journal:  N Engl J Med       Date:  2016-11-09       Impact factor: 91.245

Review 5.  Broadly neutralizing anti-HIV-1 monoclonal antibodies in the clinic.

Authors:  Marina Caskey; Florian Klein; Michel C Nussenzweig
Journal:  Nat Med       Date:  2019-04-01       Impact factor: 53.440

6.  Broadly neutralizing antibodies and viral inducers decrease rebound from HIV-1 latent reservoirs in humanized mice.

Authors:  Ariel Halper-Stromberg; Ching-Lan Lu; Florian Klein; Joshua A Horwitz; Stylianos Bournazos; Lilian Nogueira; Thomas R Eisenreich; Cassie Liu; Anna Gazumyan; Uwe Schaefer; Rebecca C Furze; Michael S Seaman; Rab Prinjha; Alexander Tarakhovsky; Jeffrey V Ravetch; Michel C Nussenzweig
Journal:  Cell       Date:  2014-08-14       Impact factor: 41.582

7.  Longitudinal Analysis Reveals Early Development of Three MPER-Directed Neutralizing Antibody Lineages from an HIV-1-Infected Individual.

Authors:  Shelly J Krebs; Young D Kwon; Chaim A Schramm; William H Law; Gina Donofrio; Kenneth H Zhou; Syna Gift; Vincent Dussupt; Ivelin S Georgiev; Sebastian Schätzle; Jonathan R McDaniel; Yen-Ting Lai; Mallika Sastry; Baoshan Zhang; Marissa C Jarosinski; Amy Ransier; Agnes L Chenine; Mangaiarkarasi Asokan; Robert T Bailer; Meera Bose; Alberto Cagigi; Evan M Cale; Gwo-Yu Chuang; Samuel Darko; Jefferson I Driscoll; Aliaksandr Druz; Jason Gorman; Farida Laboune; Mark K Louder; Krisha McKee; Letzibeth Mendez; M Anthony Moody; Anne Marie O'Sullivan; Christopher Owen; Dongjun Peng; Reda Rawi; Eric Sanders-Buell; Chen-Hsiang Shen; Andrea R Shiakolas; Tyler Stephens; Yaroslav Tsybovsky; Courtney Tucker; Raffaello Verardi; Keyun Wang; Jing Zhou; Tongqing Zhou; George Georgiou; S Munir Alam; Barton F Haynes; Morgane Rolland; Gary R Matyas; Victoria R Polonis; Adrian B McDermott; Daniel C Douek; Lawrence Shapiro; Sodsai Tovanabutra; Nelson L Michael; John R Mascola; Merlin L Robb; Peter D Kwong; Nicole A Doria-Rose
Journal:  Immunity       Date:  2019-03-12       Impact factor: 43.474

8.  Elicitation of Robust Tier 2 Neutralizing Antibody Responses in Nonhuman Primates by HIV Envelope Trimer Immunization Using Optimized Approaches.

Authors:  Matthias Pauthner; Colin Havenar-Daughton; Devin Sok; Joseph P Nkolola; Raiza Bastidas; Archana V Boopathy; Diane G Carnathan; Abishek Chandrashekar; Kimberly M Cirelli; Christopher A Cottrell; Alexey M Eroshkin; Javier Guenaga; Kirti Kaushik; Daniel W Kulp; Jinyan Liu; Laura E McCoy; Aaron L Oom; Gabriel Ozorowski; Kai W Post; Shailendra K Sharma; Jon M Steichen; Steven W de Taeye; Talar Tokatlian; Alba Torrents de la Peña; Salvatore T Butera; Celia C LaBranche; David C Montefiori; Guido Silvestri; Ian A Wilson; Darrell J Irvine; Rogier W Sanders; William R Schief; Andrew B Ward; Richard T Wyatt; Dan H Barouch; Shane Crotty; Dennis R Burton
Journal:  Immunity       Date:  2017-06-20       Impact factor: 31.745

Review 9.  Ontogeny-based immunogens for the induction of V2-directed HIV broadly neutralizing antibodies.

Authors:  Penny L Moore; Jason Gorman; Nicole A Doria-Rose; Lynn Morris
Journal:  Immunol Rev       Date:  2017-01       Impact factor: 12.988

10.  Broad and Potent Neutralizing Antibodies Recognize the Silent Face of the HIV Envelope.

Authors:  Till Schoofs; Christopher O Barnes; Nina Suh-Toma; Jovana Golijanin; Philipp Schommers; Henning Gruell; Anthony P West; Franziska Bach; Yu Erica Lee; Lilian Nogueira; Ivelin S Georgiev; Robert T Bailer; Julie Czartoski; John R Mascola; Michael S Seaman; M Juliana McElrath; Nicole A Doria-Rose; Florian Klein; Michel C Nussenzweig; Pamela J Bjorkman
Journal:  Immunity       Date:  2019-05-21       Impact factor: 31.745

View more
  1 in total

1.  Immune Responses and Viral Persistence in Simian/Human Immunodeficiency Virus SHIV.C.CH848-Infected Rhesus Macaques.

Authors:  Widade Ziani; Anya Bauer; Hong Lu; Xiaolei Wang; Xueling Wu; Katharine J Bar; Hui Li; Dongfang Liu; George M Shaw; Ronald S Veazey; Huanbin Xu
Journal:  J Virol       Date:  2021-04-12       Impact factor: 6.549

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.